Fourth quarter and full year 2021 results
Fourth quarter and full-year 2021 results will be reviewed by management during a live audio webcast with the financial community. The presentation will be followed by a Q&A session
Our commitment to fight COVID-19
Throughout the ongoing pandemic, Sanofi has joined forces to fight COVID-19 in every way possible
From Wearables to "Invisibles"
We're making it easier to participate in clinical trials from home. Find out how wireless technology can help us understand the impact of itch on sleeping children
Sanofi’s Rare Humanitarian Program Turns 30
“Our purpose is clear–to help ensure that people living with rare diseases around the world have the ability to access the treatments they need” -Paul Hudson, Chief Executive Officer
Join us!
You will join a diverse mix of people, who genuinely believe in our mission to help people around the world live healthier lives
-
Press releases2022-01-28MMMM DD YYYYSanofi and Regeneron provide regulatory update on Libtayo® (cemiplimab-rwlc) in advanced cervical cancer